The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19-Reference-Cited by-同舟云学术

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19

Published:2021-04-27 Issue:2 Volume:12 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Casadevall Arturo¹^ORCID,Pirofski Liise-anne²³,Joyner Michael J.⁴

Affiliation:

1. Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA

2. Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, New York, USA

3. Montefiore Medical Center, Bronx, New York, USA

4. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA

Abstract

Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins differ from conventional antimicrobial agents in that they mediate direct and indirect antimicrobial effects that work in concert with other components of the immune system.

Funder

HHS | National Institutes of Health

HHS | Biomedical Advanced Research and Development Authority

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mBio.03372-20

Reference78 articles.

1. Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases

2. Hepatitis after Prophylactic Serum